Endoluminal Suturing Devices Market Size, Share, Competitive Landscape and Trend Analysis Report by Application and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Therapeutic interventions to deal against obesity using bariatric endoscopy, which is affecting millions of people around the world and has now turned into a global pandemic, is steadily emerging as a preferable option in various healthcare settings. Suturing and stapling devices are mainly used in medical operatives associated with GERD and obesity. The implementation of these devices offer minimally invasive clinical procedures which is the major advantage. Traditionally, the rate of progression of clinical procedures and clinical trials was lower than the recent years owing to immense developments. Physicians extensively implement endoluminal suturing devices for endoscopic surgeries, where they are used to place thick sutures at target location with the help of flexible sutures. A tiny specialized suturing device attributed with flexibility, and is used in endoscopic surgery. Endoluminal suturing devices foster better recovery rate and satisfy consumer demand for minimally invasive medical procedures resulting into better patient experience, faster recovery, less hospital visits and shortened duration of stay in healthcare facilities. The use of advanced instruments has facilitated the acceptance of endoluminal suturing devices as well.

COVID – 19 scenario analysis: 

• The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
• Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
• Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
• Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
• Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to endoluminal suturing devices has been reduced and this segment have to face negligence subsequently causing negative impact on  endoluminal suturing devices market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Rising obese population and chronic diseases resulting into patient pools, the surging demand of minimally invasive surgeries are the prime factors driving the growth for endoluminal suturing devices market globally. Obesity has turned into a global pandemic and is critical health hazard as well as the second most preventable reason of death in U.S. The Centers for Disease Control and Prevention (CDC) stated that the obese population in the U.S. was 42%, while the people in severe obesity category in adults accounted for 9.2% in the year 2018. The endoluminal surgery satisfies patient demand for minimally invasive surgeries which are performed in a hollow organ using suturing and stapling surgical techniques. Increasing demand for endoluminal surgeries is pertaining to rising consciousness regarding benefits offered by minimally invasive procedures and reduction in post-surgical complications. These factors would elucidate the market growth for endoluminal suturing devices. Other drivers to propel the industry growth include higher number of suturing procedures, rising geriatric populace, and technical advents in the suturing devices development.

However, the dearth of dexterity to these devices and numerous functional limitations create negative impact on the endoluminal suturing devices market thereby hampering the growth. The market further faces complications as advanced wound sealing substances like fibrin, glues, and medical adhesives impose a great threat to these devices in the market. These substances are preferred by surgeons and healthcare professionals pertaining to their advantages such as easy application, decreased blood loss, rapid healing process and enhanced clinical outcomes. Furthermore, one of clauses of the U.S. Patient Protection and Affordable Care Act (PPACA), that inflicts excise tax of 2.3% medical equipment, proves to be a restrain for this market globally.

Sedentary lifestyle and obesity expected to fuel growth

The sedentary lifestyle is further expected to surge the market growth. According to World Health Organization (WHO), sedentary lifestyles proves to be fatal for around 5.3 million people every year globally, with minimum 300,000 premature deaths and US$90 billion are spent in directly as healthcare costs to reduce problems caused by obesity and sedentary lifestyle yearly in the U.S. The U.S. health organization CDC data highlights almost 35% of American children consume junk food regularly leading to diabetes, obesity, cardiovascular diseases and other health concerns. The US Department of Health and Human Service, stated only one in three children are physically active every day in the U.S. Thus, the rising sedentary lifestyle would cause cardiac problems creating opportunities for clinical nutrition market growth.

World Health Organization (WHO) in their report, mentioned the rate of obesity has tripled since 1975 worldwide. In 2016, over 1.9 billion adults belonging to age group 18 years or above were overweight and out of them, over one third of people were obese. These factors increase the risk of various health concerns due to obesity and this would create growth pockets for endoluminal suturing devices market.

Use of robotics in endoluminal suturing to drive the market growth

The robotics have been introduced in endoluminal suturing in order to resolve the challenges like use of endoluminal suturing devices in limited spaces, error reduction as well as robotic surgery also allows the surgeon to recreate human wrist movement. Furthermore, use of robotics provides the surgeon some freedom of robotic arm and offers better control of three-dimensional vision. As a result of the aforementioned factors, various manufacturers are integrating robotics in endoluminal suturing. The major utilization of endoluminal suturing devices is concentrated around the hospital segment pertaining to large number of patients undergoing gastrointestinal therapeutics in the hospitals. Thus, integration of robotics in endoluminal suturing devices would boost the market growth.

Key benefits of the report:

• This study presents the analytical depiction of the global endoluminal suturing devices industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global endoluminal suturing devices market share.
• The current market is quantitatively analyzed to highlight the endoluminal suturing devices treatment market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global endoluminal suturing devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Endoluminal suturing devices market research report:

• What are the leading market players active in the endoluminal suturing devices market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

  Endoluminal Suturing Devices Market Report Highlights

Aspects	Details
By Application	Bariatric Surgery Gastrointestinal Defects Gastroesophageal Reflux Disease
By End User	Hospitals Clinics Ambulatory Surgical Centers Others
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Creative-Biogene, Apollo Endosurgery Inc, Stryker Corporation, Johnson and Johnson, Ethicon Endo-Surgery, Inc, USGI Medical Inc., Medtronic, Covidien, Aldevron, Addgene
Other Players	Thermo Fisher Scientific Inc, Spark Therapeutics